Indiana University School of Nursing, Indianapolis, Indiana.
Cancer. 2014 Mar 15;120(6):909-17. doi: 10.1002/cncr.28355. Epub 2014 Jan 27.
To reduce the risk of adjustment problems associated with hematopoietic stem cell transplant (HSCT) for adolescents/young adults (AYAs), we examined efficacy of a therapeutic music video (TMV) intervention delivered during the acute phase of HSCT to: 1) increase protective factors of spiritual perspective, social integration, family environment, courageous coping, and hope-derived meaning; 2) decrease risk factors of illness-related distress and defensive coping; and 3) increase outcomes of self-transcendence and resilience.
This was a multisite randomized, controlled trial (COG-ANUR0631) conducted at 8 Children's Oncology Group sites involving 113 AYAs aged 11-24 years undergoing myeloablative HSCT. Participants, randomized to the TMV or low-dose control (audiobooks) group, completed 6 sessions over 3 weeks with a board-certified music therapist. Variables were based on Haase's Resilience in Illness Model (RIM). Participants completed measures related to latent variables of illness-related distress, social integration, spiritual perspective, family environment, coping, hope-derived meaning, and resilience at baseline (T1), postintervention (T2), and 100 days posttransplant (T3).
At T2, the TMV group reported significantly better courageous coping (Effect Size [ES], 0.505; P = .030). At T3, the TMV group reported significantly better social integration (ES, 0.543; P = .028) and family environment (ES, 0.663; P = .008), as well as moderate nonsignificant effect sizes for spiritual perspective (ES, 0.450; P = .071) and self-transcendence (ES, 0.424; P = .088).
The TMV intervention improves positive health outcomes of courageous coping, social integration, and family environment during a high-risk cancer treatment. We recommend the TMV be examined in a broader population of AYAs with high-risk cancers.
为降低青少年/年轻成人(AYA)造血干细胞移植(HSCT)相关调整问题的风险,我们研究了在 HSCT 急性期期间提供治疗性音乐视频(TMV)干预的疗效,以:1)增加精神视角、社会融合、家庭环境、勇敢应对和希望衍生意义的保护因素;2)降低疾病相关困扰和防御应对的风险因素;3)增加自我超越和韧性的结果。
这是一项在 8 个儿童肿瘤学组(COG)地点进行的多站点随机对照试验(COG-ANUR0631),涉及 113 名年龄在 11-24 岁之间接受清髓性 HSCT 的 AYA。参与者随机分配到 TMV 或低剂量对照组(有声读物),与 board-certified 音乐治疗师一起完成 3 周内的 6 次课程。变量基于 Haase 的疾病适应模型(RIM)。参与者在基线(T1)、干预后(T2)和移植后 100 天(T3)完成与疾病相关困扰、社会融合、精神视角、家庭环境、应对、希望衍生意义和韧性的潜在变量相关的测量。
在 T2 时,TMV 组报告的勇敢应对明显更好(效应量 [ES],0.505;P=0.030)。在 T3 时,TMV 组报告的社会融合(ES,0.543;P=0.028)和家庭环境(ES,0.663;P=0.008)明显更好,以及精神视角(ES,0.450;P=0.071)和自我超越(ES,0.424;P=0.088)的中度非显著效应量。
TMV 干预改善了高危癌症治疗期间勇敢应对、社会融合和家庭环境的积极健康结果。我们建议在更广泛的高危癌症 AYA 人群中检查 TMV。